Supha Pharmachem logo

Supha Pharmachem financials and balance sheet

BSE: 539561Commercial Services & SuppliesSmall Cap

Last close ₹0.24down ₹0.01 (4.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹0.25.

52-week range of traded prices to 23 Oct 2026
₹0.23Low, 22 Oct 2026₹1.66High, 4 Nov 2025
Market cap
₹21 Cr3,473rd largest listed
P/E
No recent results
P/B
No recent results
Dividend yield
Nonein the last 12 months
Volume, BSE
72,65,991

9 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Supha Pharmachem annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹4,042 Cr, year to Mar 2024

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2025

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue222
  2. Materials and goods−216
  3. Employee costs−0.8
  4. Other expenses−7.4
  5. Operating profit−1.8
  6. Depreciation0.0
  7. Other income+11
  8. One-off items0.0
  9. Finance costs−5.3
  10. Profit before tax3.7
  11. Tax−2.1
  12. Net profit1.5

What the company owns

  • Plant, investments and other assets₹678 Cr
  • Receivables₹591 Cr
  • Inventory₹269 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Borrowings₹1,141 Cr
  • Owed to suppliers₹321 Cr
  • Net worth₹43 Cr
  • Other liabilities₹34 Cr

Profit and loss

Standalone, ₹ crore, years to March.Supha Pharmachem quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 14 JunMar 2020Filed 16 JulMar 2021Filed 12 MayMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 25 JunMar 2025Filed 16 Jun
Revenue from operations1003905055104,042222
1003895035024,008224
Materials and goods bought1002884984944,001216
Employee costs–00001111
Other expenses–00114867
Operating profit before depreciation000012733−2
Operating margin−1.8%0.2%−43.2%13.4%0.8%0.3%1.5%0.8%−0.8%
Materials, % of revenue–39.9%28.3%57.9%97.5%98.7%96.9%99.0%97.1%
Employee costs, % of revenue–37.5%25.5%6.4%0.2%0.1%0.2%0.0%0.3%
Other expenses, % of revenue–22.5%89.4%22.3%1.6%0.8%1.5%0.2%3.3%
Depreciation and amortisation000000000
Operating profit after depreciation000012733−2
Other income00000002111
Finance costs000000045
One-off items––0000000
Profit before tax0000127504
0000002182
Net profit0000015332
Net margin0.2%4.0%5.0%9.6%0.5%0.2%1.1%0.8%0.7%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2025, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Filed 14 JunMar 2020Filed 16 JulMar 2021Filed 12 MayMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 25 JunMar 2025Filed 16 JunSep 2025Half yearFiled 14 Nov
334510434391
Share capital44444104088
Reserves−100173333
001100581,1411,088
01242191,1441,9051,4961,438
001100000
Total assets44392241,1541,9481,5401,529
000000015
44382241,1541,9481,5401,515
Net debt−1−110−1−22561,1401,086
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2025, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Filed 12 MayMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 25 JunMar 2025Filed 16 JunSep 2025Half yearFiled 14 Nov
−101121−74−1,07920
−101222−56−1,07820
−111015−111−1,08721
Receivables−22−40−108−74833026
Inventories−2−8177−126−1369
Payables23101−40627−391−1
Other working capital−103087136−889−12
Tax paid00−2−1800
Capital spending000000
Free cash flow−101121−74−1,07920
00000−14
10−110541,078−6
Dividends paid000000
Shares bought back000000
Shares issued0000048
Net change in cash0120−2000
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2019Filed 14 JunMar 2020Filed 16 JulMar 2021Filed 12 MayMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 25 JunMar 2025Filed 16 Jun
₹0.00₹0.01–₹0.03₹0.13₹0.81₹0.04
As stated that year₹0.02₹0.77–₹2.99₹15.07₹3.25₹0.04
₹0.00₹0.01–₹0.03₹0.13₹0.81₹0.04
₹0.08₹0.08₹0.10₹0.12₹0.26₹1.07₹1.07
Shareholder yield––0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)6816502661,09473
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from. As stated that year and earnings per share are left blank for the year to Mar 2017: the earnings per share is stated as 0 while the period's profit or loss comes to at least half a paisa a share, so the 0 stands in for a figure the filing does not give. As stated that year and earnings per share are left blank for the year to Mar 2021: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.

Ratios

Standalone, years to March.Supha Pharmachem PE ratio and valuation

RatioMar 2018Mar 2019Filed 14 JunMar 2020Filed 16 JulMar 2021Filed 12 MayMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 25 JunMar 2025Filed 16 Jun
Revenue growth−75.1%−54.5%1,716.6%3,015.2%460.7%1.0%692.7%−94.5%
Operating profit growth–––83.2%140.0%338.0%345.7%–
Net profit growth366.7%−42.9%3,362.6%73.5%124.3%403.5%503.2%−95.3%
Earnings per share growth––3,395.5%––403.4%503.2%−95.1%
–0.3%8.6%13.3%24.5%70.9%122.8%3.6%
––8.4 pts4.7 pts11.2 pts46.4 pts51.8 pts−119.2 pts
From the net margin––0.2 pts−8.1 pts−8.0 pts97.7 pts−17.0 pts−18.4 pts
From asset turnover––7.7 pts2.2 pts−0.5 pts−98.7 pts136.1 pts−99.3 pts
From borrowing––0.5 pts10.6 pts19.6 pts47.4 pts−67.3 pts−1.6 pts
Return on capital employed–−2.2%10.1%4.5%33.0%70.6%33.0%−0.2%
Cash conversion–––−2,125.4%1,046.9%377.8%−226.6%−70,406.4%
Interest cover––––15.3−96.98.6–
Debt to equity–0.020.112.720.000.001.3426.36
Receivable days–314189964612383969
Inventory days–1,6571531361512455
Payable days–2,8538499916265542
Cash conversion cycle, days–−88225810166730882
Working capital days–4,757324542−891,941
Asset turnover–0.050.744.213.850.742.610.13
Assets per rupee of net worth–1.151.215.9429.8290.0558.1840.43
Sales per rupee of plant––49.921,232.675,912.996,531.3486,012.0626,806.94
Capital spending to depreciation–––0.650.680.000.000.00
Plant being built, % of plant in use––0.0%0.0%0.0%0.0%–0.0%
Interest cover is left blank for the years to Mar 2017, Mar 2018 and Mar 2025: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2025.

Return on assets, latest year
0.1%
Measure10 years5 years3 years
Revenue growth, yearly rate–138.4%−23.9%
Profit growth, yearly rate–40.8%12.4%
Return on equity, average–47.0%65.7%
Return on capital employed, average–28.2%34.5%
Operating margin, average−3.2%0.5%0.5%
Net margin, average2.5%0.7%0.9%
Asset turnover, average–2.311.16
Cash conversion cycle, days, average–201326
Interest cover, average––−44.2
Debt to equity, average–6.099.24

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2025.

₹ crore5 years3 yearsLatest year
Cash from operations−1,131−1,132−1,079
Cash from investing000
Cash from financing1,1321,1321,078
Capital spending000
Dividends paid000
Shares bought back000
Shares issued for cash000
Borrowings raised1,1521,1411,084
Borrowings repaid1100

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Piotroski score, out of 9Published threshold 3 points out of 9––––45543
Altman Z-scorePublished threshold 1.1––12.469.622.660.230.130.41–
Beneish M-scorePublished threshold −1.78––––32.121.18−1.895.427.21
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––50.15−7.74−2.186.8961.94
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––3.09−1.08−28.53
Receivables growth less revenue growthOur threshold 0 percentage points–––−721.72−1,536.17−290.47168.35−258.6758.68
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−3,369.42−4,797.732,130.33−90.351,009.65196.79
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––1.300.000.010.080.040.18
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.000.000.00–0.00
Effective tax ratePublished threshold 17.16 per cent25.0017.6558.3326.1326.4029.3326.6335.13–
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−0.04−0.10−0.17–
A threshold marked as ours has no published figure; it is the line we read the check against.